Advertisement
Advertisement
U.S. markets open in 9 hours
Advertisement
Advertisement
Advertisement
Advertisement

Concert Pharmaceuticals, Inc. (CNCE)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.0400-0.0700 (-2.25%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close3.1100
Open2.9900
Bid3.0000 x 900
Ask3.2000 x 1400
Day's Range2.8001 - 3.1100
52 Week Range2.6400 - 11.2600
Volume129,516
Avg. Volume859,331
Market Cap105.366M
Beta (5Y Monthly)0.27
PE Ratio (TTM)N/A
EPS (TTM)-1.9700
Earnings DateFeb 23, 2022 - Feb 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CNCE

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Concert Pharmaceuticals, Inc.
    ENTA: Lowering target price to $66.00ENANTA PHARMACEUTICALS INC has an Investment Rating of BUY; a target price of $66.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement